Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD

Christer Janson, Georgios Stratelis, Anna Miller-Larsson, Tim Harrison, Kjell Larsson
  • International Journal of Chronic Obstructive Pulmonary Disease, October 2017, Dove Medical Press
  • DOI: 10.2147/copd.s143656

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

The following have contributed to this page: Christer Janson and Kjell Larsson